Back to company

BORREGAARD BIOPLANT ApS: Financial statements 2024

CVR: 21500445

BORREGAARD BIOPLANT ApS (CVR 21500445) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 10,402,795 and a net result of DKK 421,195 compared with DKK -753,841 the year before. That is an increase of 14.1% compared with the year before. Equity amounted to DKK 6,029,340. The solvency ratio was 60.6%. The company had 25 employees in the financial year.

Gross Profit
10,402,795 kr.
Profit/Loss
421,195 kr.
Equity
6,029,340 kr.
Total Assets
9,944,561 kr.
Employees
25

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-10.4 mio.421 t.6 mio.25
2023-9.1 mio.-754 t.5.6 mio.22
2022-10 mio.-1.5 mio.7.4 mio.21
2021-11.8 mio.900 t.9.8 mio.20
2020-11.5 mio.596 t.8.9 mio.19

Official annual report

View the official annual report directly on the page with a Pro subscription.

Events in 2024

BORREGAARD BIOPLANT ApS: The 2023 annual report is outMay 6, 2024

BORREGAARD BIOPLANT ApS has published its annual report for 2023. Gross profit came to DKK 9,116,413, and the net result was DKK -753,841.

About BORREGAARD BIOPLANT ApS

BORREGAARD BIOPLANT ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 1999. The company is registered under the industry Ikke-specialiseret engroshandel. The management consists of Martin Lemche. The company is owned by Biobest Group NV. The company has 18 employees. In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. Equity amounted to DKK 5,520,385.